DOTAREM 0.5 MG 20 ML

Product Overview: Dotarem 0.5 mmol/ml 20ml

Dotarem 0.5 mmol/ml 20ml is a renowned gadolinium-based contrast agent (GBCA) manufactured by Guerbet, a leader in the medical imaging field. This pharmaceutical solution is specifically designed to enhance contrast in Magnetic Resonance Imaging (MRI) scans, significantly improving the visualization of various anatomical structures and pathological lesions. It is routinely used in clinical settings to aid in the accurate diagnosis of conditions affecting the brain, spine, and other tissues.

Benefits of Use:

• Enhances the diagnostic quality of MRI scans by providing superior contrast for precise lesion visualization.

• Improves the detection and delineation of abnormalities in the brain, spine, and other bodily tissues.

• Contributes to a more accurate and confident diagnosis for a wide range of medical conditions.

• Aids healthcare professionals in making informed treatment decisions based on clearer imaging results.

How to Use:

1. Dotarem is administered intravenously as a sterile solution.

2. It must be administered by qualified healthcare professionals in a controlled clinical environment.

3. The dosage is carefully determined by the prescribing physician based on the patient's body weight, the specific clinical indication, and the MRI protocol.

4. The injection typically occurs shortly before or during the Magnetic Resonance Imaging (MRI) procedure.

5. Patients should be monitored during and after administration as per medical guidelines.

Caution & Warnings:

• Patients should be screened for a history of allergic reactions, asthma, or other allergic disorders.
• Risk of hypersensitivity reactions, including severe anaphylaxis. Emergency equipment and trained personnel should be readily available.
• Patients with severe renal impairment (eGFR < 30 mL/min/1.73m²) are at increased risk of Nephrogenic Systemic Fibrosis (NSF). Renal function should be assessed prior to administration.
• Use with caution in pregnant or lactating women, and only if the diagnostic information is essential and cannot be obtained with non-contrast MRI.
• Extravasation at the injection site may occur; monitor the injection site during and after administration.
• Inform your doctor if you have kidney problems, a history of seizures, or any other serious medical conditions.

Ingredients:

• **Active Ingredient:** Gadoterate Meglumine (0.5 mmol/ml)

• **Excipients:** Meglumine, Water for Injection

Product Details:

• **Brand:** Guerbet

• **Manufacturer:** Guerbet

• **Pharmaceutical Form:** Solution for injection

• **Strength:** 0.5 mmol/ml

• **Pack Size:** 20 ml vial

• **Type:** Gadolinium-based contrast agent (GBCA)

• **Route of Administration:** Intravenous

• **Legal Status:** Prescription Only Medicine (POM)